Factors to consider in the association between soy isoflavone intake and breast cancer risk
- PMID: 20173308
- PMCID: PMC3900805
- DOI: 10.2188/jea.je20090181
Factors to consider in the association between soy isoflavone intake and breast cancer risk
Abstract
It has been suggested that soy isoflavones have protective effects against breast cancer. However, data from epidemiological studies are not conclusive. A recent meta-analysis showed that soy intake was inversely associated with breast cancer risk in Asian but not Western populations, which indicates that protection against breast cancer may require that women consume levels of soy typical in Asian diets. In addition to the amount of soy isoflavones consumed, the form and food source of isoflavones, timing of isoflavone exposure, estrogen receptor status of tumors, and equol-producer status and hormonal profile of individuals may modify the association between soy isoflavone intake and the risk of breast cancer. These factors might explain the heterogeneity of results from studies. This present report contrasts background data from Japanese and Western women to identify the potential modifying of these factors.
Similar articles
-
A Review of the Clinical and Epidemiologic Evidence Relevant to the Impact of Postdiagnosis Isoflavone Intake on Breast Cancer Outcomes.Curr Nutr Rep. 2025 Mar 25;14(1):50. doi: 10.1007/s13668-025-00640-5. Curr Nutr Rep. 2025. PMID: 40131602 Free PMC article. Review.
-
Perspectives on the soy-breast cancer relation.Am J Clin Nutr. 2009 May;89(5):1673S-1679S. doi: 10.3945/ajcn.2009.26736V. Epub 2009 Apr 1. Am J Clin Nutr. 2009. PMID: 19339397
-
Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.Breast Cancer Res Treat. 2009 Nov;118(2):395-405. doi: 10.1007/s10549-009-0321-5. Epub 2009 Feb 17. Breast Cancer Res Treat. 2009. PMID: 19221874 Free PMC article.
-
Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study.Am J Clin Nutr. 2009 Jun;89(6):1920-6. doi: 10.3945/ajcn.2008.27361. Epub 2009 Apr 29. Am J Clin Nutr. 2009. PMID: 19403632 Free PMC article.
-
Epidemiology of soy exposures and breast cancer risk.Br J Cancer. 2008 Jan 15;98(1):9-14. doi: 10.1038/sj.bjc.6604145. Epub 2008 Jan 8. Br J Cancer. 2008. PMID: 18182974 Free PMC article. Review.
Cited by
-
Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.Horm Cancer. 2012 Dec;3(5-6):227-39. doi: 10.1007/s12672-012-0122-x. Epub 2012 Sep 12. Horm Cancer. 2012. PMID: 22968785 Free PMC article.
-
Correlations of urinary phytoestrogen excretion with lifestyle factors and dietary intakes among middle-aged and elderly Chinese women.Int J Mol Epidemiol Genet. 2012;3(1):18-29. Epub 2012 Feb 5. Int J Mol Epidemiol Genet. 2012. PMID: 22493748 Free PMC article.
-
Identification of Estrogen Receptor α Antagonists from Natural Products via In Vitro and In Silico Approaches.Oxid Med Cell Longev. 2018 May 10;2018:6040149. doi: 10.1155/2018/6040149. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29861831 Free PMC article.
-
Does equol production determine soy endocrine effects?Eur J Nutr. 2012 Jun;51(4):389-98. doi: 10.1007/s00394-012-0331-7. Epub 2012 Feb 25. Eur J Nutr. 2012. PMID: 22366740 Review.
-
Nutraceutical use in late-stage cancer.Cancer Metastasis Rev. 2010 Sep;29(3):503-10. doi: 10.1007/s10555-010-9240-5. Cancer Metastasis Rev. 2010. PMID: 20714787 Free PMC article. Review.
References
-
- Akiyama T , Ishida J , Nakagawa S , Ogawara H , Watanabe S , Itoh LN , et al. . Genistein, a specific inhibitor of tyrosine-specific protedin kinases . J Biol Chem. 1987;262:5592–5 - PubMed